Nearly half of breast cancer survivors in the U.S. had their care delayed in April as COVID-19 cases surged across the country, a new survey shows.
The survey includes responses from 609 breast cancer survivors, collected April 2-27. Survey results were published in the journal Breast Cancer Research and Treatment.
Sixty-three percent of the respondents said they were receiving cancer care, and the average age was 47 years.
Forty-four percent of respondents reported a delay in care. About 79 percent reported delays in routine follow-up appointments, and 30 percent reported delays in hospital-or clinic-based cancer therapies, including radiation, infusion therapies and surgical tumor removal.
Respondents also reported delays in breast reconstruction surgery (66 percent), diagnostic imaging (60 percent) and lab testing (50 percent).
More articles oncology:
Mission Health moves chemotherapy out of rural areas
Dana-Farber Cancer Institute opens center for treatment of BRCA-related cancers
How a cancer diagnosis & living through a pandemic are eerily similar
© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.